Tag: pharmaceuticals
-
FDA Approves Anti-Clotting Drug for Stroke Prevention
The U.S. Food and Drug Administration today approved the anti-clotting drug rivaroxaban to reduce the risk of stroke in people with abnormal heart rhythms from atrial fibrillation due to problems other than faulty heart valves. The drug is marketed under the name Xarelto in the U.S. by Janssen Pharmaceuticals in Raritan, New Jersey, a subsidiary…
-
Sanford-Burnham to Join Pfizer Translational Network
Sanford-Burnham Medical Research Institute in San Diego has agreed to participate with Pfizer Inc. in the pharmaceutical company’s Centers for Therapeutic Innovation (CTI), a consortium of academic labs and institutes working in translational research. Sanford-Burnham joins university medical centers and institutes in Massachusetts, New York, San Francisco and San Diego, California. Pfizer calls CTI an…
-
NIH to Fund Diabetes/Cardiovascular Biomarker Collaboration
Researchers at Arizona State University in Tempe will lead a team funded by National Institutes of Health to discover proteins or biomarkers that help predict cardiovascular disease and to assess new treatments for people with type 2 diabetes. The $5 million, four-year project will include scientists from the Phoenix VA Health Care System, Pfizer Inc.,…
-
U.S. Biotech Licenses Hong Kong University Flu Research
Alios BioPharma in South San Francisco and University of Hong Kong agreed to a licensing agreement for the university’s research findings that target influenza viruses. The agreement, officially with the university’s technology transfer company, will be used to advance the company’s R&D and commercialization of medicines to treat influenza infection. The company also agreed to…
-
Q3 Venture Investments Rise in China, Decline in Europe
Venture capital (VC) investments, according to Dow Jones VentureSource, moved in opposite directions in China and Europe during the third quarter of 2011. Dow Jones VentureSource is a database of investments from 67,000 venture-backed companies in North America, Europe, Israel, China, and India. In the third quarter, investors put $1.3 billion into 89 deals for…
-
Company, Institute Partner on Cancer Drug Candidate Catalog
Researchers at Fox Chase Cancer Center in Philadelphia and Reaction Biology Corporation in Malvern, Pennsylvania have compiled an index of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes involved with cancer. Their findings appear online in the journal Nature Biotechnology, and are also scheduled for publication…
-
FDA Approves Post-Surgical Pain Medication
Pacira Pharmaceuticals Inc. in Parsippany, New Jersey says the Food and Drug Administration has approved its drug Exparel for the management of post-surgical pain. The non-opioid local analgesic, says the company, can provide pain relief for surgical patients of up to 72 hours. Exparel combines the compound bupivacaine in the company’s DepoFoam drug delivery platform.…
-
Synthesized Methods Developed for Anti-Coagulant Drugs
Researchers at Rensselaer Polytechnic Institute in Troy, New York and University of North Carolina, Chapel Hill have developed a new method for producing the anti-coagulant drug fondaparinux that is purer, faster, and less expensive. Their findings, which the authors say offer a template for the discovery of other drugs, appear in the 28 October issue…
-
Gates Foundation, China to Partner on Health, Agriculture
The Bill & Melinda Gates Foundation and China’s Ministry of Science and Technology announced a partnership to support research and development and manufacturing of new products to improve global health and agriculture. Bill Gates and vice-minister Zhang Laiwu signed an agreement that they say affirms their focus on meeting the needs of developing countries and…
-
FDA Grant Funds Georgetown University Regulatory Center [Updated]
Update, 26 October 2011: A similar center of excellence will be established at University of Maryland in College Park, also funded by a $1 million FDA grant. Georgetown University in Washington, D.C. will establish a Center of Excellence in Regulatory Science and Innovation (CERSI), with initial funding from the U.S. Food and Drug Administration. The…